secwatch.observer — SEC 8-K summary
======================================

Issuer:     Valion Bio, Inc. (VBIO)
CIK:        0001787740
Form:       8-K/A
Filed at:   2026-08-20T20:15:14+00:00
Accession:  0001683168-26-006632
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Valion Bio stockholders authorize 1-for-5 to 1-for-50 reverse stock split
-------------------------------------------------------------------------

- Special meeting Aug 14, 2026: reverse split proposal approved with 1,243,530 for, 697,127 against, 60,678 abstain.
- Board has 12 months to set split ratio within 1-for-5 to 1-for-50 range without further stockholder approval.
- Quorum was 48.21% (2,001,335 of 4,151,259 outstanding common shares represented).
- Adjornment proposal also passed (1,242,980 for) but not used since Proposal 1 passed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1787740/000168316826006632/0001683168-26-006632-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1787740/000168316826006632/valion_8ka1.htm
  HTML page:      https://secwatch.observer/filing/0001683168-26-006632

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer